Company news: FCC, Novo, Sanofi

Share this article:
The FCC's mobile health task force convened in June to assess how to leverage mobile in the health space, and offered up its findings this week, reported MobiHealth. Among the recommendations – that the FCC should be the lead and promote greater use of mobile health technologies and that federal agencies need to collaborate to “promote innovation, protect patient safety and avoid regulatory duplication.” The initiative uses the term mobile to include remote patient monitors, software applications, body sensors that capture data, implants, patient care portals and mobile diagnostic imaging applications.

Novo Nordisk is expanding its Beijing footprint. The Danish drug maker announced Tuesday that it was investing an additional $100 million in science facilities there. The expansion includes more room and space for 70 new hires to boost its science staff to 200 employees.

Sanofi released a bout of less-bad news Tuesday: the company, which labor unions expected to lay off close to 2,500 employees, is rounding down the number to about 900 positions cut in France by 2015. The company said in a statement it expects the drop off to consist of “early retirements, mobility proposals and repositioning in France.” Bloomberg noted that Labor Unions put the at-risk total at around 1,500.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.